Clinical trial

Multiple Ascending Dose Study of MHS552 in Adults With Type 1 Diabetes Mellitus

NCT05272059

Study summary

ClinicalTrials.gov

Multiple Ascending Dose Study of MHS552 in Adults With Type 1 Diabetes Mellitus

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention MHS552 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2023-09-01

PhasePHASE1

Conditions

Type 1 Diabetes Mellitusverified · MONDO: type 1 diabetes mellitus

Interventions

MHS552DRUG

PlaceboDRUG

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05272059 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.